Cell cycle phase determines efficacy of bortezomib, temozolomide and MAPK inhibitor-induced apoptosis in melanoma

Hill, D. S., Beaumont, K. A., Daignault, S. M., Sharp, D. M., Gabrielli, B., Weninger, W. and Haass, N. K. (2016). Cell cycle phase determines efficacy of bortezomib, temozolomide and MAPK inhibitor-induced apoptosis in melanoma. In: Experimental Dermatology. 43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF), Vienna Austria, (E42-E42). Mar 10-12, 2016.

Author Hill, D. S.
Beaumont, K. A.
Daignault, S. M.
Sharp, D. M.
Gabrielli, B.
Weninger, W.
Haass, N. K.
Title of paper Cell cycle phase determines efficacy of bortezomib, temozolomide and MAPK inhibitor-induced apoptosis in melanoma
Conference name 43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF)
Conference location Vienna Austria
Conference dates Mar 10-12, 2016
Proceedings title Experimental Dermatology   Check publisher's open access policy
Journal name Experimental Dermatology   Check publisher's open access policy
Publication Year 2016
Sub-type Published abstract
ISSN 0906-6705
Volume 25
Issue 3
Start page E42
End page E42
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: UQ Diamantina Institute Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sun, 24 Apr 2016, 10:19:00 EST by System User